FAQ/Help |
Calendar |
Search |
Today's Posts |
|
Myasthenia Gravis For support and discussions on Myasthenia Gravis, Congenital Myasthenic Syndromes and LEMS. |
|
Thread Tools | Display Modes |
09-11-2010, 06:37 PM | #1 | ||
|
|||
Member
|
First I apologize for not writing down where I found this info but it was from some clinical journal place..lol, that's the best I can say. Here goes:
There are 6 treatment strategies: 1) Targets antigen specific B-Cells 2) Targets antigen Specific CD4+ T-Cells 3) Targets intereference with co-stimulatory response for antigen presentation 4) Target is aimed at inducing tolerance or anergy of CD4+ T-Cells to autoantigen or the CD4+ epitopes 5) Treatment is designed to stimulate the immunological circuits which activate CD8+ cells specific for activation antigens expressed by CD4+ cells 6) Treatment intervenes with the cytokine function and discourages the autoimmune mediated inflamatory responses. So, what does this all mean-in normal language!! I understand some but I will keep studying and go in to next neuro visit fully armed for a good debate! I feel like a naughty child who just found Santa's presents under me mom's bed!!! I want to know by the lab results or whatever exam the WHY of my future treatments> OHHH I feel like I am about to get a handle or control over this mystery. giggle,giggle,giggle. |
||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
New treatment targets found for ALS | ALS News & Research | |||
PD treatment strategies update; Unmet needs of PD patients | Parkinson's Disease |